Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
|
|
Integrated Regional Information Networks - November 3, 2004
JOHANNESBURG (PLUSNEWS) - People living with HIV/AIDS in Zambia could soon benefit from the local manufacture of anti-AIDS drugs.
PHARCO, a pharmaceutical firm partly owned by the government, announced that it was ready to begin a three-month drug trial on 28 HIV-positive volunteers.
A senior PHARCO employee said the firm would start full production of antiretroviral drugs once the trials had ended successfully.
A local newspaper, the Daily Mail, quoted PHARCO general manager Johan Richter as saying: "The plant will be able to produce a quantity of at least 150,000 treatments per year. Production capacity will be increased when and if required."
041103
IR041111
Copyright © 2004 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .